We are live on ! Find out more
Temasek Holdings

Temasek Holdings Portfolio holdings

AUM $37.3B
1-Year Est. Return 12.6%
This Fund
S&P 500
This Quarter Est. Return
+13.5%
1 Year Est. Return
+12.6%
3 Year Est. Return
+93.72%
5 Year Est. Return
+64.47%
10 Year Est. Return
+501.94%
AUM
$15.5B
AUM Growth
+$2.1B
Cap. Flow
+$472M
Cap. Flow %
3.04%
Top 10 Hldgs %
80.2%
Holding
61
New
21
Increased
4
Reduced
6
Closed
2

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 38.44%
2 Industrials 25.96%
3 Healthcare 13.86%
4 Communication Services 6.21%
5 Materials 5.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$281B
$5B 32.24%
35,495,289
LVLT
2
DELISTED
Level 3 Communications Inc
LVLT
$3.86B 24.86%
65,031,667
INFO
3
DELISTED
IHS Markit Ltd. Common Shares
INFO
$932M 6.01%
21,173,310
GILD icon
4
Gilead Sciences
GILD
$187B
$787M 5.08%
11,125,816
-3,318,400
-23% -$221M
UNVR
5
DELISTED
Univar Solutions Inc.
UNVR
$414M 2.67%
14,171,599
+5,996
+0% +$182K
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$12.9B
$315M 2.03%
3,472,712
PYPL icon
7
PayPal
PYPL
$47B
$289M 1.86%
5,387,963
JD icon
8
JD.com
JD
$38.2B
$287M 1.85%
7,306,572
TCOM icon
9
Trip.com Group
TCOM
$25.8B
$285M 1.84%
5,297,205
PTLA
10
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$274M 1.77%
4,883,568
-1,700,000
-26% -$68.1M
TMO icon
11
Thermo Fisher Scientific
TMO
$227B
$262M 1.69%
1,503,087
-111,600
-7% -$18.7M
VIRT icon
12
Virtu Financial
VIRT
$5.69B
$217M 1.4%
12,317,682
AR icon
13
Antero Resources
AR
$12.1B
$211M 1.36%
9,755,618
TRQ
14
DELISTED
Turquoise Hill Resources Ltd
TRQ
$194M 1.25%
7,321,388
PPG icon
15
PPG Industries
PPG
$25B
$190M 1.22%
1,727,645
NFX
16
DELISTED
Newfield Exploration
NFX
$180M 1.16%
+6,326,046
New +$208M
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$177M 1.14%
1,452,922
+226,292
+18% +$26.3M
ZTO icon
18
ZTO Express
ZTO
$15.9B
$170M 1.1%
12,176,750
GRA
19
DELISTED
W.R. Grace & Co.
GRA
$158M 1.02%
+2,187,501
New +$153M
V icon
20
Visa
V
$700B
$143M 0.92%
1,522,287
RDS.B
21
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$133M 0.86%
2,449,948
+2,041,405
+500% +$114M
AMZN icon
22
Amazon
AMZN
$2.79T
$128M 0.82%
2,634,700
AVGO icon
23
Broadcom
AVGO
$1.7T
$87.6M 0.56%
+3,760,500
New +$87.2M
REGN icon
24
Regeneron Pharmaceuticals
REGN
$85.2B
$87.2M 0.56%
177,553
+51,202
+41% +$22.4M
TOUR
25
Tuniu
TOUR
$54.8M
$65.8M 0.42%
819,444

Similar funds

Temasek Holdings's Q2 2017 Portfolio in Review

As of Q2 2017, Temasek Holdings held 61 positions worth $15.5B, up 16% from $13.4B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Temasek Holdings deployed $472M of net new capital in Q2 2017, opening 21 new positions and adding to 4 existing holdings. Its largest new stake was Newfield Exploration: 6,326,046 shares worth $180M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Gilead Sciences, an estimated $221M trimmed.

  • Temasek Holdings's largest Q2 2017 buy was Newfield Exploration: 6,326,046 shares worth $180M.
  • Temasek Holdings added most to Royal Dutch Shell PLC ADS Class B in Q2 2017, an estimated $114M increase.
  • Temasek Holdings's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $221M.
  • Temasek Holdings fully exited Dell in Q2 2017, selling an estimated $77.3M.
  • Temasek Holdings's ten largest holdings make up 80% of its $15.5B portfolio in Q2 2017.
  • Temasek Holdings opened 21 new positions and closed 2 in Q2 2017.
  • Temasek Holdings's portfolio value rose 16% quarter-over-quarter to $15.5B.

Based on Temasek Holdings's 13F filing for Q2 2017, filed 14 Aug 2017.